The ATFa proteins, which are members of the CREB/ ATF family of transcription factors, display quite versatile properties. We have previously shown that they interact with the adenovirus E1a oncoprotein, mediating part of its transcriptional activity and heterodimerize with the Jun, Fos or related transcription factors, thereby modulating their DNA-binding speci®city. In the present study, we report the sequence requirement of the N-terminal activation domain of ATFa and demonstrate the importance of speci®c threonine residues (Thr51 and Thr53) in addition to that of the metalbinding domain, in transcriptional activation processes. We also show that the N-terminal domain of ATFa which stably binds the Jun N-terminal kinase-2 (JNK2) (Bocco et al., 1996) , is not a substrate for this kinase in vivo but, instead, serves as a JNK2-docking site for ATFa-associated partners like JunD, allowing them to be phosphorylated by the bound kinase.
Introduction
Cells respond to extracellular stimuli through biochemical processes that involve the interplay of multiple intracellular signalling pathways, resulting in stimulation of a number of protein kinase cascades. These kinases ultimately phosphorylate a selected assortment of transcription factors acting through speci®c DNA sequences in the genome, thereby positively or negatively aecting their transcriptional properties. Two examples of such DNA regulatory elements are the ATF/CRE and the TRE motifs, which dier by only one nucleotide in their consensus sequence (TGACGTCA and TGACTCA, respectively). These motifs have been shown to be the targets for the CREB/ATF and AP1 transcription factors which bind as homodimers or as various combinations of heterodimers (Whitmarsh and Davis, 1996) . AP1 has previously been shown to be the essential component of the response to genotoxic agents and cellular stress. Both AP1 subunits, which are members of the Fos and Jun families of oncoproteins (Angel and Karin, 1991) , are regulated by phosphorylation (Whitmarsh and Davis, 1996) . Protein kinases belonging to the MAPK family have been implicated in this regulation, particularly the Jun N-terminal-Kinases (JNKs) or Stress Activated Protein Kinases (SAPKs). Members of this JNK/SAPK subgroup of MAP kinases are activated in response to a variety of extracellular stimuli, including UV irradiation, mitogens and cytokines (Kyriakis and Avruch, 1996; Minden and Karin, 1997) . The JNKs were initially identi®ed by their ability to bind the N-terminus of the c-Jun protein, on a site (now de®ned as the docking site) encompassing amino acids 33 ± 47, and to subsequently phosphorylate the Ser63 and Ser73 residues (Whitmarsh and Davis, 1996; Minden and Karin, 1997) . Phosphorylation of these sites stimulates the ability of c-Jun to activate transcription of speci®c target genes by a mechanism which remains largely unknown: it has been proposed, for example, that this phosphorylation may indirectly protect c-Jun from ubiquitinylation, thereby prolonging its half-life (Fuchs et al., 1996 (Fuchs et al., , 1997 ; alternatively, this phosphorylation may induce the dephosphorylation of Thr231, Ser243 and Ser249 residues and, as a consequence, increase cJun DNA-binding activity (Papavassiliou et al., 1995) .
The three Jun proteins c-Jun, JunB and JunD share strong sequence homologies but exhibit distinct expression patterns: both junB and c-jun are considered as immediate ± early response genes, based on their rapid and extensive transcriptional induction following cell stimulation; on the other hand, junD is predominantly expressed in quiescent cells (Wang et al., 1996) , and its overexpression in proliferating cells decreases their growth rate (Minden and Karin, 1997) . Among these three members of the Jun family, only cJun is an ecient JNK substrate: JunB contains an eective JNK docking site but lacks consensus JNK phosphorylation sites; conversely, JunD harbours proper JNK phosphorylation sites but lacks an eective JNK docking site. However, combinations between these Jun proteins may give rise to JNKresponsive heterodimers which will activate transcription .
The JNKs have recently been found to phosphorylate and activate other transcription factors like Elk1 (Cavigelli et al., 1995) or ATF2 (Gupta et al., 1995; Livingstone et al., 1995; van Dam et al., 1995) . ATF2 forms homodimers but can also readily heterodimerize with other members of the ATF and Jun/Fos families (Benbrook and Jones, 1990; Hai and Curran, 1991; Lee, 1992) , thus yielding factors with extended regulatory potentials. ATF2 has indeed been found to mediate transcriptional activation of speci®c target genes by adenovirus E1a (Maekawa et al., 1991; Flint and Jones, 1991; Green, 1990, 1993) or by stress-inducing agents (van Dam et al., 1995) . While residues 20 ± 60 of ATF2 are required for binding of JNK1, phosphorylation occurs on two closely spaced residues (Thr69 and Thr71) located within the Nterminal activation domain of ATF2 (Gupta et al., 1995; Livingstone et al., 1995) .
We have characterized human polypeptides (ATFa1, ATFa2 and ATFa3) (Gaire et al., 1990; Chatton et al., 1993) , functionally related to ATF2, that are translated from alternatively spliced messengers resulting from a common primary transcript . A transcriptional activation domain that comprises an essential zinc-binding element has been delineated in the N-terminal part of the ATFa proteins. This N-terminal element, together with sequences located in the Cterminal portion of the ATFa proteins, contributes to their interaction with the E1a oncoprotein (Chatton et al., 1993) . In vitro and in vivo experiments have demonstrated that the ATFa proteins can associate with c-Jun or c-Fos proteins and that they bind TRE sequences only when heterodimerized with members of the Jun family (Chatton et al., 1994) . These results indicate that the ATFa proteins, together with other members of the ATF/CRE binding proteins, like ATF2, may play important functions in the early events of cell signalling. The ATFa proteins also strongly bind the JNK2 protein kinase and this interaction has been documented both in vitro and inside the cell (Bocco et al., 1996) .
In the present study, because of the identical behaviour of the three isoforms, we focused only on ATFa1. We report the sequence requirement of the Nterminal activation domain of ATFa and demonstrate the importance of speci®c threonine residues. We show that these residues play a central role in E1a-mediated transcriptional activation. The contribution of ATFa to the transactivation process involving the Jun proteins and the JNK is also described.
Results
Residues Thr51, Thr53 and to a lesser extent Thr112 are required for ATFa function ATFa sequence analysis revealed the existence of two clusters of aminoacids (TPTPT), conserved in ATF2 and c-Jun ( Figure 1A ). The ®rst two threonine residues of each of these motifs (Thr69 and 71 in ATF2, and Thr91 and 93 in c-Jun), which correspond to potential MAP kinase target sites (Marshall, 1995) , have been shown to be essential for the transcriptional activity of ATF2 (Gupta et al., 1995; Livingstone et al., 1995) and to contribute to that of c-Jun (Hibi et al., 1993; Derijard et al., 1994; Papavassiliou et al., 1995) . To examine the relevance of the corresponding Thr51, 53, 156 and 158 residues to the activity of ATFa, all four residues were converted to alanine, either separately or in combination, and the mutated proteins were assayed for their capacity to activate transcription. In order to avoid any potential interference with endogenous ATF proteins, we used the Gal4 protein fusion system (Liu and Green, 1990) to study the eect of these alterations. Recombinant vectors expressing the wild type or mutated ATFa1 proteins fused to the yeast Gal4 DNA-binding domain (G4-ATFa1 chimeras; Figure 2B ) were transfected into cultured cells, together with a G4-TK-CAT reporter plasmid ( Figure   2A ), and comparatively tested for their ability to stimulate reporter activity (Chatton et al., 1993 (Chatton et al., , 1994 . The following studies were arbitrarily focused on the ATFa1 variant, since initial transcription studies with ATFa1, ATFa2 and ATFa3 gave very similar results (Chatton et al., 1994 and data not shown).
The results of such experiments are presented in Figure 2B (column a). As previously reported (Chatton et al., 1994) , the full-length ATFa proteins exhibited only moderate transcriptional activity when assayed in this system. Compared to the relative CAT activity measured when the reporter was transfected alone (about 0.4, not shown), cotransfection of the G4-ATFa wt vector raised relative CAT activity to 1.0 (line 1). By contrast, deletion of the C-terminal half of ATFa (as in the G4-ATFa1D vector) resulted in a tenfold higher reporter stimulation (line 10). This higher activity likely resulted from the unmasking of the ATFa activation domain by the removal of the 200 most C-terminal residues of the protein, previously suspected to hinder ATFa intrinsic activity (Chatton et al., 1994) . We therefore decided to analyse the mutations in the context of both full-length and truncated ATFa molecules.
A mutation [C14A], altering the zinc-binding element of ATFa severely aected reporter stimulation (lines 2 and 11), in agreement with our earlier conclusion that the integrity of this metal-binding element is crucial to the ATFa activation function (Chatton et al., 1993 (Chatton et al., , 1994 . These results clearly indicated that only the most N-terminal TPTPT cluster, comprising threonine residues 51 and 53, was essential for ATFa transactivation. Furthermore, substitution of these residues by aspartate, as in the double mutant [T51D, T53D], also diminished ATFa activity, both in the full-length (line 6) and truncated (line 13) constructs, indicating that the actual space-®lling of threonine residues at these positions is important and cannot be replaced by negativelycharged units. Single point mutations are marked by vertical bars. Constructs are named according to the coordinates of the aminoacids which were altered or deleted (D) (see Materials and methods). COS-7 cells were cotransfected with the G4-TK-CAT reporter vector (2.5 mg) and the G4-ATFa1 expression vectors (0.1 mg), either alone (column a) or together with plasmids (0.5 mg) expressing the E1a (column b) or the JNK2 (column c) proteins, or the corresponding control vectors (pE1a 7 and pTL1, respectively). About 36 h after transfection, the cells were collected and assayed for CAT activity. Values given in column (a) correspond to the ratios of the CAT activity of each ATFa variant to the activity of the G4-ATFa1 wt construct. The values given in columns (b and c) for each ATFa construct represent the ratio of the CAT activities measured in the presence of E1a and JNK2, respectively, to those found in the presence of the corresponding control vectors. Values in parentheses represent fold activation by E1a (column b) and JNK2 (column c) and correspond to the ratios of relative CAT activities in columns b and c to those in column a, respectively. (C) JNK2 7/7 cells were cotransfected with the G4-TK-CAT reporter gene (2.5 mg), the chimeric G4-ATFa1 constructs (0.5 mg) and either the JNK2 expression vector (0.5 mg) or the corresponding control vector (pTL1). After 36 h, the cells were harvested and assayed for CAT activity. Relative CAT activities and fold activations by JNK2 (values in parentheses) were expressed as in (B) . The values presented are the means of at least four independent experiments and standard deviations always stayed within 20% of the experimental values Figure 1B ). In c-Jun, this element occurs twice and comprises serine residues 63 and 73, which correspond to the target sites of the Jun Nterminal kinase (JNK2) (Hibi et al., 1993; . In ATFa this element is unique, centred on Thr112. Mutagenesis of this residue to a glycine, as in recombinant [T112G] , also reduced ATFa transactivation capacity ( Figure 2B , column a, lines 7 and 15), although to a lesser extent than alteration of Thr51 and 53. The simultaneous alteration of all three threonine residues, as in mutant [T51A, T53A, T112G], completely abolished ATFa activity (lines 9 and 16). Together, these results demonstrate that, in addition to the N-terminal metal-binding structure, threonine residues 51, 53 and 112 constitute essential elements of the ATFa transactivation domain.
ATFa-mediated transcriptional activation by E1a occurs through the ATFa activation domain
Previous studies have demonstrated that the transactivation potential of ATFa was strongly enhanced by the adenovirus 289-residue (289R) E1a oncoprotein and that conserved region 3 (CR3) of E1a was crucial for this eect (Chatton et al., 1993) . Moreover, this protein and, to a lesser extent, its shorter 243R counterpart have been shown to directly associate with two regions of ATFa, one encompassing the leucine-zipper region and the other comprising the essential N-terminal zincbinding element (Chatton et al., 1993) .
We examined the eect of the critical ATFa mutations on the E1a transactivation properties.
and [T51A, T53A, T112G] were no longer activated by the E1a 289R product ( Figure 2B , column b, compare lines 1 and 10 with lines 2, 5, 7, 9 and lines 11 and 12), revealing that the corresponding mutations compromise both ATFa activity and E1a-responsiveness. Furthermore, alteration of ATFa residues 156 and 158, which had no eect on ATFa activity, had also no eect on E1a-mediated reporter activation (column b, lines 8 and 14), indicating that these residues do not contribute to either activation process. Since the same ATFa residues are required for both basal and E1a-induced activities, it is likely therefore that induction by E1a directly involves the ATFa activation domain.
JNK2 activates both full-length and truncated ATFa
We recently reported that ATFa strongly interacts with JNK2 and that this interaction depends on the integrity of the 80 N-terminal residues of ATFa (Bocco et al., 1996) that de®ne the ATFa activation domain. To examine the eect of JNK2 on ATFa activity, cells were transfected with a selected series of G4-ATFa constructs, together with the G4-TK-CAT reporter, and cotransfected with a JNK2 expression vector.
We ®rst examined the eect of overexpressing JNK2 in COS-7 cells (the same results were obtained in F9 cells, not shown). As revealed by reporter activity measurements ( Figure 2B , column c), JNK2 stimulated G4-ATFa transcriptional activity (lines 1 and 10). This activation was abolished by mutations that disrupted the ATFa zinc-binding element and altered the threonine residues 51 and 53, as in mutants [C14A] and [T51A, T53A], respectively (lines 2, 5, 11 and 12). On the other hand, alteration of the threonine residues 112, 156 and 158 (lines 14 and 15) had essentially no eect. Since the b-LZ domain of ATFa was dispensable for this eect, these results strongly suggest that the observed JNK2-mediated reporter activation occurred direclty through ATFa and not through any potential dimerization partner. Furthermore, the ATFa activation domain, as de®ned above, was critically involved in this process.
We also examined the eect of JNK2 on the activity of ATFa, in a JNK2-null background. To this end, JNK2 7/7 ®broblasts were transfected under the same conditions as described above. In these cells, the truncated G4-ATFa1D protein exhibited basal-level activity, as alteration of the ATFa activation domain (as in mutants [C14A] and [T51A, T53A]) did not further reduce reporter activity ( Figure 2C, column a) . Expression of JNK2 restored G4-ATFa1D transcriptional activity (column b), clearly indicating that there is a functional link between the ATFa activation domain and JNK2.
ATFa is phosphorylated in vivo, but JNK2 is not involved in this phosphorylation
We have previously shown that ATFa can be phosphorylated by associated protein kinase activities, under in vitro assay conditions (Bocco et al., 1996) . To determine whether ATFa could also be phosphorylated in vivo, we cotransfected COS-7 cells with vectors expressing either the wild type or N-terminally truncated derivatives of ATFa proteins. After labelling the cells with 32 P-orthophosphate, extracts were prepared and ATFa proteins were immunoprecipitated with speci®c antibodies and separated by SDS ± PAGE. As shown in Figure 3A , labelled ATFa proteins were readily detected in the transfected cell extracts (panel P, lane 1), indicating that ATFa is indeed phosphorylated in vivo. Furthermore, by the combined examination of protein accumulation and phosphorylation, it appeared from the deletion analysis (panels P and W, lanes 2 ± 4) that phosphorylation occurred exclusively on sites located within the 180 N-terminal aminoacid residues of the protein, mainly within a region spanning residues 101 ± 180. Interestingly, a computer search of potential phosphorylation sites revealed that putative kinase sites were spread throughout the entire ATFa1 sequence. Clearly, only those located within the Nterminal third of the protein were used under our labelling conditions. The possibility exists however that a sequence element located within the ®rst 180 residues may supply a kinase docking site for downstream phosphorylation.
We have in fact previously shown that JNK2 binds to a region located within the N-terminal 82 residues of ATFa: deletion of this region did not signi®cantly reduce the overall level of ATFa phosphorylation (compare signals of wt and D2-100 in Figure 3A ). This observation suggested that ATFa is not a substrate for this JNK2 kinase. To examine more directly the potential contribution of JNK2 to the in vivo phosphorylation of ATFa, JNK2 7/7 ®broblasts were transfected with vectors expressing the chimeric G4-ATFa1D protein or its [T51A, T53A] derivative, ATFa/JNK2/Jun association F De Graeve et al both retaining the phopsphoacceptor domain comprised within the 180 N-terminal aminoacid residues. The extent of phosphorylation of these ATFa proteins was monitored before and after cotransfection with a vector expressing JNK2, combined or not with a UV treatment of the recipient cells ( Figure 3B , panel P). As shown in Figure 3B (panel W), nearly identical amounts of ATFa proteins were synthesized under each experimental condition. Clearly, the basal level of in vivo phosphorylation of the G4-ATFa1D protein was not reduced by the [T51A, T53A] mutation (panel P, compare lanes 1 and 5), indicating that these threonine residues, are not the major targets of this phosphorylation. Furthermore, expression of JNK2 and/or UV irradiation of the transfected cells resulted in no detectable stimulation of G4-ATFa1 phosphorylation (lanes 2 ± 4 and 6 ± 8), whereas in a control experiment, performed in parallel under the same conditions, phosphorylation of the RXRa receptor protein was strongly increased (compare lanes 9 ± 12) (S Adam and C Rochette-Egly, manuscript in preparation). Finally, a tryptic phosphopeptide mapping within the N-terminal part of ATFa revealed no signi®cant modi®cation of the ATFa phosphorylation pattern, before and after UV treatment, after transfection of either the G4-ATFa1D or G4-ATFa1D [T51A, T53A] recombinants (Figure 4) . Together, these results indicate that ATFa, while strongly associated to the JNK2 protein, is not an in vivo substrate for this protein kinase.
In ATFa/Jun heterodimers the transcriptional function is mostly due to the Jun partner, while ATFa essentially contributes to JNK2 recruitment
As reported earlier (Chatton et al., 1994 (Chatton et al., , 1995 , ATFa can heterodimerize with members of the Jun family and thereby alter their DNA binding speci®cities and transcriptional properties. Thus, c-Jun and JunD, when co-expressed with G4-ATFa, were each able to enhance reporter activity ( Figure 5B , line 1, compare columns a, b and e). As expected, the b-LZ element of ATFa was P-orthophosphate and extracts were prepared. Aliquots (200 mg protein) of each extract were treated with the 1A7 Mab. Immunoprecipitated proteins were separated by SDS ± PAGE, transferred onto nitrocellulose and revealed by autoradiography (P), followed by Western blotting (W) using the 1A7 Mab and the ECL detection system. (B) ATFa phosphorylation is not aected by JNK proteins and UV treatment. JNK2
7/7 cells were transfected with vectors expressing the G4-ATFa1D, G4-ATFa1D [T51A, T53A] (1 mg, see Figure 2 ) and RXRa proteins. Where indicated, the cells were cotransfected with a JNK2 expression vector (1 mg). Two days after transfection, cells were labelled with 32 P-orthophosphate for 3 h and, where indicated, treated with UV. Extracts were prepared and aliquots (200 mg protein) of each extract were precipitated with the anti-ATFa 2F10 Mab (lanes 1 ± 8) or anti-RXRa (lanes 9 ± 12) antibodies. Immunoprecipitated proteins were separated by SDS ± PAGE, transferred onto nitrocellulose and revealed by autoradiography (P), followed by Western blotting (W) using the anti-ATFa 2F10 (lanes 1 ± 8) or anti-RXRa (lanes 9 ± 12) antibodies and the ECL detection system Figure 4 Comparative phosphopeptide analysis of ATFa. Cos-7 cells were transfected with vectors expressing the G4-ATFa1D, G4-ATFa1D[T51A, T53A] (1 mg, see Figure 2 ). Two days after transfection, cells were labelled with 32 P-orthophosphate for 3 h and, where indicated, treated with UV. Extracts were prepared and aliquots (200 mg protein) of each extract were precipitated with the anti-ATFa 2F10 Mab antibodies. Immuno-precipitated proteins were separated by SDS ± PAGE, transferred onto PVDF membranes, revealed by autoradiography. The radiolabelled ATFa protein was protease digested and the eluted peptides were fractionated by electrophoresis and subsequently by ascending chromatography, as described (Boyle et al., 1991) . The origin (O) and major phosphopeptides (1 ± 5) revealed after autoradiography (15 days at 7808C with intensifying screen) are indicated ATFa/JNK2/Jun association F De Graeve et al critically required for this eect (Chatton et al., 1994) . In the case of c-Jun, this activation was independent of the integrity of the ATFa activation domain, strongly suggesting that, within the ATFa/c-Jun partnership, cJun was predominantly responsible for the activation function (column b, lines 2 ± 4).
From the functional dissection of c-Jun, a model had emerged where a domain spanning residues 33 ± 47 of c-Jun constitutes a docking site for the JNK/SAP kinase. Once recruited onto this N-terminal element, the kinase may activate c-Jun by phosphorylating residues Ser63 and Ser73 . In addition, while bound to c-Jun, the JNK/SAP kinase may also phosphorylate dimerization partners of c-Jun: thus, JunD which lacks a proper JNK docking element but possesses phosphoacceptor sites identical to those of c-Jun, may be phosphorylated by a kinase docked onto the c-Jun moiety of a JunD/c-Jun heterodimer .
With this model in mind, we examined the role of the JNK2 docking site of ATFa in the transcriptional activation process by ATFa/Jun heterodimers. Vectors were constructed (see Figure 5A ) which expressed mutated forms of c-Jun lacking either the Ser63 and Ser73 phosphoacceptor sites (as in mutant [S63A, S73A]) or the JNK docking site (as in mutant [D33 ± 47]). These Jun recombinants were transfected into F9 cells (which express low levels of endogenous c-Jun protein [Angel and Karin, 1991] and our unpublished observation), together with a selected series of G4-ATFa1 constructs. The transcriptional activity of the resulting combinations was assayed on the G4-TK-CAT reporter ( Figure 5B ).
As expected, the c-Jun Ser63 and Ser73 residues were critically required for ecient promoter activatioan, irrespective of the nature of the cotransfected (Bocco et al., 1996) . Consistent with this, a c-Jun mutant deleted for both phosphoacceptor and docking sites (as in mutant [D33 ± 77]) exhibited no stimulation activity in the presence of any of the G4-ATFa constructs (not shown).
It appears therefore that, within the ATFa/c-Jun heterodimers, c-Jun provides most of the activation function and that this function depends on the presence of a neighbouring docking site for the JNK/SAP kinase. Furthermore, our results indicate that deletion of such a binding site from Jun can be compensated in heterodimers with ATFa where the ATFa partner will ensure recruitment of the kinase, thereby enabling cJun activation.
Unlike c-Jun, JunD has no JNK/SAPK docking site, but possesses a phosphoacceptor site identical to that of c-Jun . Despite the absence of a proper docking site, JunD eciently triggered reporter activation when overexpressed with the wt G4-ATFa ( Figure 5B , column e, line 1). Deletion of the JNK docking site in ATFa (as in mutant [D1 ± 100], line 4) completely abolished this activation. Together, these results further support the conclusion that ATFa provides its own docking site to the kinase that will phosphorylate and thereby activate JunD. Figure  2 ), the chimeric G4-ATFa1 constructs (0.5 mg) and either the c-Jun or JunD expression vectors (0.5 mg) or the corresponding control vector (pTL1). After 36 h, the cells were harvested and assayed for CAT activity. Relative CAT activities and fold activations by each Jun variant (values in parentheses) were expressed as in Figure 2B . The values presented are the means of at least four independent experiments and standard deviations always stayed within 20% of the experimental values 
Discussion
The three major members of the ATFa family of transcription factors (ATFa1, 2 and 3) have no intrinsic transcriptional activity in their native form. A bona ®de activation domain could however be revealed by truncation of the C-terminal part of the ATFa polypeptide. In the present study we report the detailed peptidic sequence requirement of this activation domain and examine its function in the context of ATFa-mediated E1a activation and ATFa-Jun heterodimeric complexes.
The ATFa activation domain spans the N-terminal metal-binding element and comprises threonine residues 51 and 53
We have previously shown that the N-terminal zincbinding element is an essential component of the ATFa activation domain (Chatton et al., 1993 (Chatton et al., , 1994 . Our present results demonstrate that the two threonine residues 51 and 53 and, to a lesser extent threonine residue 112, also contribute to the activation domain. Strikingly, the activation function of this domain was detected only after removal of C-terminal parts of ATFa, suggesting that the activation domain is masked by distant portions of the molecule. A systematic deletion mapping of ATFa has previously located a potential inhibitory region between residues 393 and 494, just C-terminal to the b-LZ element (Chatton et al., 1993) . The precise nature and function of this inhibitory domain are presently unclear. In this respect, the presumed mechanism of ATFamediated activation by E1a may be informative. We have shown here that the ATFa sequence elements required for the stimulation of reporter activity by E1a are the same as those constituting the ATFa activation domain. In keeping with our original ®nding that E1a simultaneously interacts with elements located within the N-terminal and C-terminal parts of ATFa (Chatton et al., 1993) , it is tempting to speculate that E1a acts, at least in part, by unmasking the ATFa activation domain, thereby stimulating transcription activity. In addition, once recruited to target promoters by virtue of its interactions with ATFa, E1a may also directly act on the transcriptional machinery. This is best illustrated by the yet higher reporter activity observed, in the presence of E1a, with a truncated ATFa fusion protein lacking the C-terminal inhibitory domain ( Figure 2B , line 10, compare columns a and b). As expected, this overstimulation of reporter activity by E1a was abolished by mutations altering the ATFa activation domain since these mutations also prevent binding of E1a to the truncated ATFa molecule (Chatton et al., 1993 and unpublished observations) .
Role of the ATFa threonine residues 51 and 53
The threonine residues 51 and 53 are part of a sequence element (TPTPT) that is also found in ATF2 and c-Jun (see Figure 1) . In all three cases, this element contributes to the transcriptional activity of the corresponding protein (Allegretto et al., 1990; Derijard et al., 1994; Gupta et al., 1995; Livingstone et al., 1995; Papavassiliou et al., 1995 and present study) . Although this element represents a potential MAP kinase target site (Marshall, 1995) , it does not appear to be a major in vivo phosphorylation site of ATFa, as point-mutations altering threonine residues 51 and 53 clearly do not reduce the overall extent of ATFa phosphorylation in COS-7 (not shown) or JNK2 null cells ( Figure 3B ). Together with the fact that overexpression of JNK2 and/or UV-treatment of these cells had no detectable eect on ATFa phosphorylation, these results indicate (i) that the ATFa threonine residues 51 and 53 are not major targets for JNK2 and (ii) that phosphorylation of these residues does not seem critical for ATFa transcriptional activity. This conclusion is further corroborated by our observation that these residues cannot be functionally substituted by the negatively charged aspartate residue.
It is striking that, despite the strong interaction existing between the two proteins (Bocco et al., 1996) , ATFa is not a substrate for JNK2 when assayed in this cellular context ( Figure 3B ), whereas it was an ecient enzymatic target for the associated JNK2 when assayed in vitro, after immunoprecipitation of the complex (Bocco et al., 1996) . We have no explanation for this apparent discrepancy, other than putting forward the higher speci®city of the in vivo reaction. On the other hand, overexpression of JNK2 stimulates ATFa transcriptional activity and this stimulation is dependent on the presence of ATFa threonine residues 51 and 53 and on the integrity of the ATFa metal-binding domain (Figure 2 ). In agreement with our earlier mapping experiments of the JNK2-interacting region of ATFa which pointed to the 80 N-terminal ATFa residues (Bocco et al., 1996) , these results suggest that JNK2 binds to an element comprising the ATFa activation domain. However, instead of being a substrate for the bound JNK2, ATFa may carry the kinase to a distinct, close by or associated acceptor protein(s).
ATFa, a JNK carrier
We have previously shown that ATFa can heterodimerize with Jun proteins in vivo, generating transcriptionally active complexes (Chatton et al., 1994 (Chatton et al., , 1995 . This heterodimerization alters the original DNA binding speci®city of the proteins by directing the resulting protein complexes on targets that they would not bind as homodimers. As an example, heterodimerization of ATFa or ATF2-related factors with members of the Jun family allows Jun proteins to bind CRE sequences and thus to activate promoters that could not be activated by AP1 complexes or Jun ATFa/JNK2/Jun association F De Graeve et al homodimers (Hai and Curran, 1991; Lee, 1992; Chatton et al., 1994) . We show here that ATFa contributes only moderately to the transcriptional activity of these heterodimers and that the activation function is mostly provided by the Jun partner. We conclude therefore that ATFa (and most likely also the ATF2-related proteins) serves primarily to redirect the Jun proteins to new targets, thereby increasing the Juncontrolled repertoire. In an elegant study, van Dam et al. (1998) recently showed that overexpression of a cJun mutant with preferential binding to ATF2-like proteins induced growth factor independence, thus providing direct evidence for the physiological relevance of such heterodimeric interactions.
Speci®c phosphorylation of the Jun factors by the JNK proteins is an essential prerequisite for their transcriptional activity (Karin, 1995 and references therein) . As demonstrated here, the ability of ATFa to act as a JNK2-docking partner may thus be exploited in heterodimers with Jun proteins, like JunD, that lack their own JNK-docking site.
It has been reported that, in F9 cells, the TRE motifs present within the promoter of the c-jun gene are bound by heterodimers composed of dierent ATF and Jun proteins (van Dam et al., 1993) . While ATFa behaves like a housekeeping protein and is ubiquitously expressed (Goetz et al., 1996 and unpublished observations) , the various Jun partners are expressed at distinct levels in F9 cells, depending on their growth state. Thus, in quiescent cells, c-Jun is barely detectable, whereas JunD, relatively abundant, appears in a hypophosphorylated (i.e. inactive) form. After stress-mediated stimulation of the cells, JunD undergoes a transient burst of phosphorylation (Wang et al., 1996) , leading to c-Jun promoter activation. To complete the picture, the following sequence of events may be inferred from our present ®ndings: after cell treatment with stressinducing agents, activated JNK2 is recruited by ATFa into ATFa/JunD heterodimers where it may phosphorylate and thereby activate JunD; eventually, this may result in c-Jun promoter stimulation and increased cJun expression. Following c-Jun accumulation, ATFa/cJun heterodimers (or c-Jun homodimers) would in turn replace ATFa/JunD heterodimers and ultimately lead to the induction of cell proliferation (van Dam et al., 1995; Wang et al., 1996) .
JNK-mediated phosphorylation might also play a role in the stabilization of the cellular partners of ATF proteins. It has indeed been shown that phosphorylation by JNK protects substrates from JNK-targeted ubiquitinylation and subsequent proteolytic degradation (Fuchs et al., 1996 (Fuchs et al., , 1997 Musti et al., 1997) . Interestingly, we recently identi®ed UBC9, a ubiquitin conjugating enzyme (Kovalenko et al., 1996) , as a potential partner of ATFa, using a two-hybrid screen in yeast (unpublished results). While the physiological relevance of this observation remains to be con®rmed, it suggests that the ATFa proteins are involved in the ®ne-tuning of gene expression, by enrolling speci®c enzymatic proteins to their target promoters: they may not only contribute to the recruitment of speci®c activators (E1a) to these promoters and heterodimerize with other factors (Jun, Fos), but also act as a docking site for distinct enzymes (JNK, UBC9) and thereby modulate the activation and/or half-life of these partners.
Materials and methods

Recombinant plasmids
The G4-ATFa1 recombinants and derivatives encode the DNA-binding domain of the yeast GAL4 protein fused to the wild type (wt) or mutated ATFa1 polypeptide, as described (Chatton et al., 1994) . The ATFa coordinates refer in each case to the numbering of the aminoacid residues of the largest ATFa protein (ATFa3, 494 residues) (Chatton et al., 1993 (Chatton et al., , 1994 . The pc-jun and JunD vectors, which encode the wild type c-Jun (c-Jun wt) and JunD polypeptides, respectively, were a kind gift from B Wasylyk (Strasbourg). Point-mutations (S63A, S73A) and deletion variants (D33 ± 47 and D33-77) were derivd from this vector. The pRXRa (Leid et al., 1992) vector was a gift from C Rochette-Egly. The G4-TK-CAT reporter (Webster et al., 1988) contains the CAT gene, driven by the HSV thymidine kinase (TK) promoter (7105/+51) and bears a single GAL4 binding site inserted 5' to the TK promoter (see Figure 2) . The pJNK2 was a gift from M Karin (Kallunki et al., 1994) . Plasmid pE1a comprises the entire Ad2 E1a transcription unit (0 ± 4.5 map units), with an SV40-derived poly-adenylation site. pE1a
7 is an E1a-defective recombinant which derives from pE1a by deletion of the E1a transcribed sequences located downstream to position +129 (Le et al., 1984) . pTL1 is an expression vector derived from pSG5 .
Point-mutations and deletions were created in the ATFa1 and c-Jun sequences by oligonucleotide-directed mutagenesis (Kunkel et al., 1987) , PCR-ampli®cation of appropriate DNA fragments or restriction fragment deletion. All constructions were veri®ed by DNA sequencing. The pointmutations were denominated according to their positions in the corresponding polypeptide (number), with the letter before and after the number representing the wild type and substituting residues, respectively. Deletions were denoted by D.
Cells, transfections, UV treatment, labelling and CAT assays COS-7 and F9 cells were grown as monolayers, as previously reported (Bocco et al., 1996; Angel and Karin, 1991) . JNK2 7/7 ®broblasts were isolated as follows: primary embryo ®broblast cultures were prepared from 12.5 day embryos derived from intercrosses of siblings of JNK2 7/7 mice; immortalization and the establishment of 3T3-like cell lines was performed as described in Brusselbach et al. (1995) . These JNK 7/7 cells were maintained in Dulbecco's modi®ed MEM supplemented with 10% fetal calf serum.
Cells were transfected by calcium-phosphate coprecipitation (Chen and Okayama, 1987) , 8 h after plating, with recombinant plasmids (adjusted to 15 mg per 9 cm Petri dish with double-stranded pSP65 carrier DNA). The medium was changed after 20 h. The next day, the cells were harvested in ice-cold phosphate-buered saline, pelleted, washed once in the same buer and resuspended in lysis buer (0.4 M KCl, 20 mM Tris-HCl, pH 7.5, 20% glycerol, 5 mM dithiothreitol, 0.4 mM phenyl-methyl-sulfonyl-¯uoride, 1 mM sodium fluoride and 0.2 mM sodium ortho-vanadate). After one freezethawing step in liquid nitrogen, the resulting cell lysate was cleared by centrifugation for 20 min at 10 000 g ( Kumar and Chambon, 1988) .
Before treatment with UV (40 J/m 2 ), cells were grown overnight in the presence of 0.5% fetal calf serum (low serum condition). Metabolic labelling with 32 P was performed by incubation of the cells for 3 ± 4 h before harvesting, in phosphate-free medium (Eagle's modi®ed MEM) supplemented with [ 32 P]-orthophosphate (0.5 mCi/ml) (NEN). Phosphopeptide mapping was performed as described (Boyle et al., 1991) .
Aliquots of the extracts (normalized by protein concentration) were assayed for CAT activity as previously described (Gorman et al., 1982) . Each transfection experiment was repeated at least four times with dierent plasmid preparations. Per cent acetylation of chloramphenicol was determined by thin layer chromatography followed by quantitation using a Bioimager analyser (Fuji Photo Film Co. Ltd). The values always agreed to within 20% from one experiment to the other.
Antibodies, immunoprecipitation and blotting
Monoclonal antibodies against ATFa were produced by injecting puri®ed, bacterially produced ATFa3 protein (2F10 Mab) or a peptide encompassing aminoacids 350 ± 364 (1A7 Mab) (Chatton et al., 1994) . Monoclonal antibodies against RXRa (4RX3A2 and RPRXRa A) were a gift from C Rochette-Egly (Rochette-Egly et al., 1994) . Cell extracts were immunoprecipitated essentially as previously described (Ivashkiv et al., 1990) . After one step of preclearing with protein A-Sepharose, speci®c antibodies were added to the extracts (50 ± 200 mg protein), in a buer adjusted to 20 mM Tris-HCl, pH 7.8, 0.1% SDS, 0.5% deoxycholate, 0.5% nonidet P40, 150 mM NaCl (RIPA buer) (Chatton et al., 1994) . After 90 min at 48C, 30 ml of protein A-Sepharose suspension (Pharmacia) were added and incubated for an additional hour. The Sepharose beads were washed 4 times in 500 ml RIPA buer and the proteins adsorbed to the beads were separated on SDS ± PAGE. Phosphorylation was revealed by 32 P autoradiography. ATFa and RXRa proteins were revealed by immuno-blotting with speci®c monoclonal anti-ATFa and RXRa antibodies (Bocco et al., 1996) . Blocking, washing and incubation of the membrane with antibodies were carried out in PBS containing 3% defatted dry milk and 0.1% Tween 20. Protein/antibody complexes were visualized by an enhanced chemi-luminescence (ECL) Western-blotting detection system (Amersham) according to the recommendation of the manufacturer.
